Background and Purpose: The purpose of this study was to measure the temporal profile of expression of the endothelial nitric oxide synthase (NOS) in cerebral microvessels after middle cerebral artery occlusion in the rat.
Oc cclusion of the middle cerebral artery (MCA) causes severe reduction of blood flow and progressive impairment of the microcirculation in the ischemic region.1 Possible mechanisms for microvascular obstruction include endothelial luminal membrane tags,2 endothelial cell swelling,3 and polymorphonuclear leukocyte adherence to endothelium.4 Studies are now emerging that suggest that the production of endothelium-derived relaxing factor/nitric oxide (NO) by endothelial cells may significantly influence the basal tone of cerebral vessels,5-7 and the modulation of NO synthesis can lead to cerebral vascular endothelial changes and alteration of cerebral blood flow. 8 Using 24 Although alteration in NOS expression and thereby NO may have important physiological effects on ischemic brain tissue, to our knowledge there have been no investigations on the changes in NOS expression induced by focal ischemia. The aim of the present study was, therefore, to measure the temporal profile of endothelial expression of NOS in the brain by using a specific monoclonal antibody to type III NOS in a rat model of focal cerebral ischemia produced by occlusion of the MCA. nonimmune mouse serum IgG (Becton Dickinson) at a 1:10 000 dilution, which represents the same IgG concentration as the primary antibody. Preabsorption was performed by preincubating MAb H32 at a 1:1000 dilution with equal volumes of excess antigen (approximately 10 to 15 times more than the primary antibody). Absorption was carried out for 1 hour at 37°C followed by overnight incubation at 4°C. Absorbed MAb H32 was tested by immunohistochemistry and was compared with unabsorbed MAb H32. A section centered in the lesion, corresponding to the coronal section at interaural 8.2 mm, bregma 0.8 mm,27 was selected from each animal for evaluation of endothelial NOS expression. Adjacent coronal sections were stained with hematoxylin and eosin and were examined at high magnification by light microscopy for neuronal and inflammatory cell morphology. The slides were evaluated by two people, one of whom was blinded to the experiment.
Materials and Methods
Scales were used to provide a semiquantitative evaluation of NOS-like immunoreactivity. Both the percentages of positive-stained microvessels and the intensity of these vessels were accounted for. The intensity of microvasculature immunoreactivity was graded as either faint (1) or intense (2) . The percentages of the microvascular immunoreactivity were graded as follows: <2%=0; 2% to 10%=1; 11% to 50%=2; and >50%=3. In nonischemic control animals, in which large vessels stain positive for NOS, therefore, a value of "0" is provided where <2% of the vessels are immunoreactive.
Results Arterial blood gas values were within normal physiological ranges in all animals. MCA occlusion was confirmed at autopsy in all ischemic rats by observing that the tip of the filament was located in the proximal segment of the anterior cerebral artery. Immunoreactivity was absent with nonimmune mouse serum IgG and with the absorbed MAb H32 in all rats.
In the control animals neuronal damage was not detected, and type III NOS-like immunoreactivity was localized only to the endothelial layers of large vessels (Fig 1) and the choroid plexus.
In animals subjected to MCA occlusion, neuronal shrinkage and swollen neurons were observed 1 to 2 (Fig 2) . By 4 to 6 hours after MCA occlusion, the ischemic lesion involved the supraoptic area, the basal ganglia, and the cortex. Neuronal shrinkage and swollen neurons were prominent in the lesion (Fig 3A) . At this time a numerous microvessels exhibited intense type III NOS staining throughout the damaged region (Fig 3B) .
Eosinophilic neurons became evident and progressed to ghost cells from 24 to 48 hours throughout the ischemic region (Fig 4A) (Fig 5) . The distorted and fragmented vessels displayed dense type III NOS staining throughout the infarcted zone through 168 hours of ischemia (Fig 6) . lium-derived NO in cerebral vascular endothelial function after focal ischemia in the rat. Discussion Our data indicated that type III NOS is expressed in the endothelial layers of large vessels and the choroid plexus in the normal rat brain. This is consistent with data from previous reports that basal production of NO is dependent on cerebral vessel size and is greatest in the large arteries5 and that NO has an important modulating effect on basal perfusion of the choroid plexus. 30 The most important finding in the present study was that after focal cerebral ischemia type III NOS was rapidly upregulated in the cerebral microvasculature throughout the ischemic region as well as in the periphery of the area of necrosis in the cortices at 24 hours of ischemia. 
